Cargando…

A20 (TNFAIP3) Deletion in Epstein-Barr Virus-Associated Lymphoproliferative Disorders/Lymphomas

A negative regulator of the nuclear factor (NF)-κB pathway, A20 (TNFAIP3), is inactivated in several types of lymphomas; particularly in diffuse large B-cell lymphoma (DLBCL), classical Hodgkin's lymphoma, and extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue. These fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Midori, Sato, Yasuharu, Takata, Katsuyoshi, Nomoto, Junko, Nakamura, Shigeo, Ohshima, Koichi, Takeuchi, Tamotsu, Orita, Yorihisa, Kobayashi, Yukio, Yoshino, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572056/ https://www.ncbi.nlm.nih.gov/pubmed/23418597 http://dx.doi.org/10.1371/journal.pone.0056741

Ejemplares similares

Clinicopathological analysis of methotrexate‐associated lymphoproliferative disorders: Comparison of diffuse large B‐cell lymphoma and classical Hodgkin lymphoma types
por: Gion, Yuka, et al.
Publicado: (2017)

Clinicopathologic Analysis of Localized Nasal/Paranasal Diffuse Large B-Cell Lymphoma
por: Toda, Hiroko, et al.
Publicado: (2013)

Interleukin 13-positive mast cells are increased in immunoglobulin G4-related sialadenitis
por: Takeuchi, Mai, et al.
Publicado: (2015)

Up-regulation of activation-induced cytidine deaminase and its strong expression in extra-germinal centres in IgG4-related disease
por: Gion, Yuka, et al.
Publicado: (2019)

A subset of ocular adnexal marginal zone lymphomas may arise in association with IgG4-related disease
por: Ohno, Kyotaro, et al.
Publicado: (2015)

De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression
por: Igawa, Takuro, et al.
Publicado: (2013)

Epstein-Barr Virus Genome Deletions in Epstein-Barr Virus-Positive T/NK Cell Lymphoproliferative Diseases
por: Wongwiwat, Wiyada, et al.
Publicado: (2022)

Epstein–Barr Virus-Positive Mucocutaneous Ulcer: A Unique and Curious Disease Entity
por: Ikeda, Tomoka, et al.
Publicado: (2021)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
por: Ishikawa, Eri, et al.
Publicado: (2021)

Frequent downregulation of BTB and CNC homology 2 expression in Epstein–Barr virus‐positive diffuse large B‐cell lymphoma
por: Noujima‐Harada, Mai, et al.
Publicado: (2017)

X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
por: Mukai, Takeo, et al.
Publicado: (2023)

Induction and progression of human lymphoproliferative lesions by Epstein-Barr virus.
por: Chappuis, B B, et al.
Publicado: (1990)

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders
por: Cai, Qingqing, et al.
Publicado: (2015)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
por: Kim, Wook Youn, et al.
Publicado: (2019)

Primary Gastrointestinal T-Cell Lymphoma and Indolent Lymphoproliferative Disorders: Practical Diagnostic and Treatment Approaches
por: Nishimura, Midori Filiz, et al.
Publicado: (2021)

Association of Epstein-Barr virus with an angioimmunoblastic lymphadenopathy-like lymphoproliferative syndrome.
por: White, A. C., et al.
Publicado: (1989)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2019)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
por: Ban, Yumiko, et al.
Publicado: (2020)

Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms
por: Barros, Mario Henrique M., et al.
Publicado: (2023)

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
por: Sankararaman, Senthilkumar, et al.
Publicado: (2014)

Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
por: Latour, Sylvain, et al.
Publicado: (2018)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
por: Crombie, Jennifer L., et al.
Publicado: (2019)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
por: Ai, Junhong, et al.
Publicado: (2018)

Reappraisal of nodal Epstein‐Barr Virus‐negative cytotoxic T‐cell lymphoma: Identification of indolent CD5(+) diseases
por: Yamashita, Daisuke, et al.
Publicado: (2018)

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features
por: Kawamoto, Keisuke, et al.
Publicado: (2018)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma
por: Nomoto, Junko, et al.
Publicado: (2012)

Multiple small tumor formation on both surfaces of the aortic valve cusps in Epstein–Barr virus-associated T/NK-cell lymphoproliferative disease: a case report
por: Tai, Ryuta, et al.
Publicado: (2021)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
por: Kwun, Yoojin, et al.
Publicado: (2014)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
por: Yachie, Akihiro
Publicado: (2018)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
por: Kim, Hyun-Jung, et al.
Publicado: (2017)

Epstein-Barr virus-associated post-transplant lymphoproliferative disorders: beyond chemotherapy treatment
por: Shahid, Sanam, et al.
Publicado: (2021)

The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
por: Biggi, Alison Felipe Bordini, et al.
Publicado: (2022)

Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions
por: Shiraiwa, Sawako, et al.
Publicado: (2020)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
por: Hong, Mineui, et al.
Publicado: (2015)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

An Adult Case of Severe Chronic Active Epstein-Barr Virus Infection with T-Cell Lymphoproliferative Disorder
por: Mun, Se-Kwon, et al.
Publicado: (2012)

A Case of Severe Chronic Active Epstein-Barr Virus Infection with T-cell lymphoproliferative Disorder
por: Cho, Hyun Seok, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_10sgs920p1goqtvludbsjncutt